Elanco Animal Health Incorporated Securities Litigation

If you purchased a significant amount of shares of Elanco Animal Health Incorporated (NYSE: ELAN), you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:Elanco Animal Health Incorporated
Date Filed:May 20th, 2020
Sector:Health Care
Industry:Major Pharmaceuticals
Class Start Date:January 10th, 2020
Class End Date:May 6th, 2020

According to the Complaint, Elanco Animal Health Incorporated is an animal health company that develops, manufactures, and markets products for companion and food animals.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) that, after consolidating its distributors from eight to four, the Company increased the amount of inventory, including companion animal products, held by each distributor; (2) that Elanco's distributors were not experiencing sufficient demand to sell through the inventory; (3) that, as a result, the Company's revenue was reasonably likely to decline; (4) that, as a result of the foregoing, Elanco would reduce its channel inventory with respect to companion animal products; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Elanco Animal Health Incorporated

First Identified Complaint

Sandra Hunter, et al. v. Elanco Animal Health Incorporated, et al.

Date Filed:May 20th, 2020
Class Period Start:January 10th, 2020
Class Period End:May 6th, 2020
First Identified Complaint Filings
#Document TitleFiling Date